Armata Pharmaceuticals (ARMP) Receivables - Net (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Receivables - Net of $100000.0 for Q1 2026, down 80.0% sequentially from $500000.0 in Q4 2025, and down 50.0% YoY from $200000.0 in Q1 2025.
Armata Pharmaceuticals (ARMP) Receivables - Net (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Receivables - Net for 9 years, with the latest figure at $100000.0 in Q1 2026.
- Quarterly Receivables - Net fell 50.0% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (down 50.0% YoY) and the FY2025 annual result came in at $500000.0, down 28.57% from the prior year.
- Receivables - Net slipped to $100000.0 in Q1 2026 per ARMP's latest filing, from $500000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $2.2 million in Q2 2025 and troughed at $100000.0 in Q1 2026.
- A 4-year average of $912500.0 and a median of $600000.0 in 2024 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net tumbled 53.33% in 2024, then jumped 340.0% in 2025.
- Over 4 years, Receivables - Net stood at $1.5 million in 2023, then sank by 53.33% to $700000.0 in 2024, then retreated by 28.57% to $500000.0 in 2025, then tumbled by 80.0% to $100000.0 in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $100000.0, $500000.0, and $2.2 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Jun 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Dec 31, 2023 | 1.50 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Mar 31, 2017 | 15,000.00 |
| Mar 31, 2017 | 15,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Dec 31, 2016 | 12,000.00 |